Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)

ABSTRACT:

SUBMITTER: Abrisqueta P 

PROVIDER: S-EPMC11152604 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature